DC
ACHN

Deere & Company’s Achillion Pharmaceuticals ACHN Stock Holding History

Deere & Company’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-42,709
Closed -$461K – 1261
2015
Q4 		$461K Buy
+42,709
New +$388K 0.03% 594
2015
Q3 		– Sell
-60,478
Closed -$536K – 1097
2015
Q2 		$536K Buy
+60,478
New +$572K 0.03% 616
2015
Q1 		– Sell
-64,910
Closed -$795K – 1103
2014
Q4 		$795K Buy
64,910
+44,750
+222% +$546K 0.04% 457
2014
Q3 		$201K Buy
+20,160
New +$187K 0.01% 882
2013
Q3 		– Sell
-20,914
Closed -$171K – 1103
2013
Q2 		$171K Buy
+20,914
New +$160K 0.01% 901

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deere & Company's ACHN Position: Q1 2016 in Review

Deere & Company sold out of Achillion Pharmaceuticals (ACHN) in Q1 2016, closing a stake of 42,709 shares — an estimated $461K sold.

Deere & Company first reported a position in ACHN in Q2 2013 and held it in 5 quarters. The position peaked at $795K in Q4 2014. 153 funds tracked by Wall St. Rank hold ACHN as of Q1 2016.

  • Deere & Company reported no remaining Achillion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 42,709 Achillion Pharmaceuticals shares in Q1 2016, an estimated $461K.
  • Deere & Company first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Deere & Company's Achillion Pharmaceuticals position peaked at $795K in Q4 2014.
  • 153 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.